K. A. Franklin, C. Sahlin, H. Stenlund, and E. Lindberg, Sleep apnoea is a common occurrence in females, Eur. Respir. J, vol.41, pp.610-615, 2013.

S. A. Sands, Enhanced upper-airway muscle responsiveness is a distinct feature of overweight/obese individuals without sleep apnea, Am. J. Respir. Crit. Care Med, vol.190, pp.930-937, 2014.

A. E. Beaudin, X. Waltz, P. J. Hanly, and M. J. Poulin, Impact of obstructive sleep apnoea and intermittent hypoxia on cardiovascular and cerebrovascular regulation, Exp. Physiol, vol.102, pp.743-763, 2017.

E. Sforza and F. Roche, Chronic intermittent hypoxia and obstructive sleep apnea: an experimental and clinical approach, Hypoxia Auckl. NZ, vol.4, pp.99-108, 2016.

A. R. Nelson, M. D. Sweeney, A. P. Sagare, and B. V. Zlokovic, Neurovascular dysfunction and neurodegeneration in dementia and Alzheimer's disease, Biochim. Biophys. Acta BBA Mol. Basis Dis, vol.1862, pp.887-900, 2016.

, Scientific RepoRtS |, vol.10, 2020.

A. Baril, Biomarkers of dementia in obstructive sleep apnea, Sleep Med. Rev, vol.42, pp.139-148, 2018.

W. Pan and A. J. Kastin, Can sleep apnea cause Alzheimer's disease?, Neurosci. Biobehav. Rev, vol.47, pp.656-669, 2014.

H. M. Engleman and M. R. Wild, Improving CPAP use by patients with the sleep apnoea/hypopnoea syndrome (SAHS), Sleep Med. Rev, vol.7, pp.81-99, 2003.

S. Olsen, S. Smith, and T. P. Oei, Adherence to continuous positive airway pressure therapy in obstructive sleep apnoea sufferers: a theoretical approach to treatment adherence and intervention, Clin. Psychol. Rev, vol.28, pp.1355-1371, 2008.

D. C. Lim and A. I. Pack, Obstructive sleep apnea and cognitive impairment: Addressing the blood-brain barrier, Sleep Med. Rev, vol.18, pp.35-48, 2014.

B. T. Hawkins and T. P. Davis, The blood-brain barrier/neurovascular unit in health and disease, Pharmacol. Rev, vol.57, pp.173-185, 2005.

V. Muoio, P. B. Persson, and M. M. Sendeski, The neurovascular unit-concept review, Acta Physiol. Oxf. Engl, vol.210, pp.790-798, 2014.

N. J. Abbott, Blood-brain barrier structure and function and the challenges for CNS drug delivery, J. Inherit. Metab. Dis, vol.36, pp.437-449, 2013.

T. Wanek, S. Mairinger, and O. Langer, Radioligands targeting P-glycoprotein and other drug efflux proteins at the blood-brain barrier, J. Label. Compd. Radiopharm, vol.56, pp.68-77, 2013.

C. Puech, Assessment of HBEC-5i endothelial cell line cultivated in astrocyte conditioned medium as a human blood-brain barrier model for ABC drug transport studies, Int. J. Pharm, vol.551, pp.281-289, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01892564

N. J. Abbott, L. Rönnbäck, and E. Hansson, Astrocyte-endothelial interactions at the blood-brain barrier, Nat. Rev. Neurosci, vol.7, pp.41-53, 2006.

R. C. Janzer and M. C. Raff, Astrocytes induce blood-brain barrier properties in endothelial cells, Nature, vol.325, pp.253-257, 1987.

D. E. Eigenmann, Comparative study of four immortalized human brain capillary endothelial cell lines, hCMEC/D3, hBMEC, TY10, and BB19, and optimization of culture conditions, for an in vitro blood-brain barrier model for drug permeability studies, Fluids Barriers CNS, vol.10, p.33, 2013.

K. Hayashi, Effects of hypoxia on endothelial/pericytic co-culture model of the blood-brain barrier, Regul. Pept, vol.123, pp.77-83, 2004.

P. Ballabh, A. Braun, and M. Nedergaard, The blood-brain barrier: an overview: structure, regulation, and clinical implications, Neurobiol. Dis, vol.16, pp.1-13, 2004.

M. D. Sweeney, A. P. Sagare, and B. V. Zlokovic, Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders, Nat. Rev. Neurol, vol.14, pp.133-150, 2018.

H. Tan, L. Kheirandish-gozal, and D. Gozal, Sleep, sleep disorders, and immune function, Allergy and sleep: basic principles and clinical practice, pp.3-15, 2019.

P. M. Macey, Sex-specific hippocampus volume changes in obstructive sleep apnea, NeuroImage Clin, vol.20, pp.305-317, 2018.

J. A. Palomares, Water exchange across the blood-brain barrier in obstructive sleep apnea: an MRI diffusion-weighted pseudo-continuous arterial spin labeling study: altered BBB function in OSA, J. Neuroimaging, vol.25, pp.900-905, 2015.

L. Kheirandish-gozal, Regional brain tissue integrity in pediatric obstructive sleep apnea, Neurosci. Lett, vol.682, pp.118-123, 2018.

A. Ahmad, A. Taboada, C. B. Gassmann, M. Ogunshola, and O. O. , Astrocytes and pericytes differentially modulate blood-brain barrier characteristics during development and hypoxic insult, J. Cereb. Blood Flow Metab. Off. J. Int. Soc. Cereb. Blood Flow Metab, vol.31, pp.693-705, 2011.

V. Berezowski, C. Landry, M. Dehouck, R. Cecchelli, and L. Fenart, Contribution of glial cells and pericytes to the mRNA profiles of P-glycoprotein and multidrug resistance-associated proteins in an in vitro model of the blood-brain barrier, Brain Res, vol.1018, pp.1-9, 2004.
URL : https://hal.archives-ouvertes.fr/hal-00540890

D. M. Hermann, Role of drug efflux carriers in the healthy and diseased brain, Ann. Neurol, vol.60, pp.489-498, 2006.

M. Jablonski, D. S. Miller, P. Pasinelli, and D. Trotti, ABC transporter-driven pharmacoresistance in Amyotrophic Lateral Sclerosis, Brain Res, vol.1607, pp.1-14, 2015.

T. Katsuno, Deficiency of zonula occludens-1 causes embryonic lethal phenotype associated with defected yolk sac angiogenesis and apoptosis of embryonic cells, Mol. Biol. Cell, vol.19, pp.2465-2475, 2008.

M. Saitou, Complex phenotype of mice lacking occludin, a component of tight junction strands, Mol. Biol. Cell, vol.11, pp.4131-4142, 2000.

S. Kook, H. S. Hong, M. Moon, and I. Mook-jung, Disruption of blood-brain barrier in Alzheimer disease pathogenesis, Tissue Barriers, vol.1, p.23993, 2013.

J. E. Donahue and C. E. Johanson, Apolipoprotein E, amyloid-?, and blood-brain barrier permeability in Alzheimer disease, J. Neuropathol. Exp. Neurol, vol.67, pp.261-270, 2008.

E. Cuevas, Amyloid Beta 25-35 induces blood-brain barrier disruption in vitro, Metab. Brain Dis, 2019.

H. Jiao, Z. Wang, Y. Liu, P. Wang, and Y. Xue, Specific role of tight junction proteins claudin-5, occludin, and ZO-1 of the bloodbrain barrier in a focal cerebral ischemic insult, J. Mol. Neurosci, vol.44, pp.130-139, 2011.

B. Poller, J. Drewe, S. Krähenbühl, J. Huwyler, and H. Gutmann, Regulation of BCRP (ABCG2) and P-glycoprotein (ABCB1) by cytokines in a model of the human blood-brain barrier, Cell. Mol. Neurobiol, vol.30, pp.63-70, 2010.

A. M. Hartz, B. Bauer, G. Fricker, and D. S. Miller, Rapid modulation of P-glycoprotein-mediated transport at the blood-brain barrier by tumor necrosis factor-alpha and lipopolysaccharide, Mol. Pharmacol, vol.69, pp.462-470, 2006.

D. S. Miller, ABC transporter regulation by signaling at the blood-brain barrier: relevance to pharmacology, Adv. Pharmacol. San Diego Calif, vol.71, pp.1-24, 2014.

D. S. Miller, Regulation of ABC transporters blood-brain barrier: the good, the bad, and the ugly, Adv. Cancer Res, vol.125, pp.43-70, 2015.

A. Alberti, Plasma cytokine levels in patients with obstructive sleep apnea syndrome: a preliminary study, J. Sleep Res, vol.12, pp.305-311, 2003.

R. Nadeem, Serum inflammatory markers in obstructive sleep apnea: a meta-analysis

, J. Clin. Sleep Med. JCSM Off. Publ. Am. Acad. Sleep Med, vol.9, pp.1003-1012, 2013.

D. Unnikrishnan, J. Jun, and V. Polotsky, Inflammation in sleep apnea: an update, Rev. Endocr. Metab. Disord, vol.16, pp.25-34, 2015.

L. Kheirandish-gozal, H. Tan, and D. Gozal, Sleep-related breathing disorders and inflammation: TNF-? and IL-6 as prototypic examples, Allergy and sleep: basic principles and clinical practice, pp.227-245, 2019.

H. E. De-vries, The influence of cytokines on the integrity of the blood-brain barrier in vitro, J. Neuroimmunol, vol.64, pp.37-43, 1996.

A. Voirin, N. Perek, and F. Roche, Inflammatory stress induced by a combination of cytokines (IL-6, IL-17, TNF-?) leads to a loss of integrity on bEnd. 3 endothelial cells in vitro BBB model, Brain Res, vol.1730, p.146647, 2020.

A. Khalyfa, D. Gozal, and L. Kheirandish-gozal, Plasma extracellular vesicles in children with OSA disrupt blood-brain barrier integrity and endothelial cell wound healing in vitro, Int. J. Mol. Sci, vol.20, p.6233, 2019.

A. Khalyfa, D. Gozal, and L. Kheirandish-gozal, Plasma exosomes disrupt the blood-brain barrier in children with obstructive sleep apnea and neurocognitive deficits, Am. J. Respir. Crit. Care Med, vol.197, pp.1073-1076, 2018.

, Scientific RepoRtS |, vol.10, 2020.

I. Jullian-desayes, Impact of obstructive sleep apnea treatment by continuous positive airway pressure on cardiometabolic biomarkers: a systematic review from sham CPAP randomized controlled trials, Sleep Med. Rev, vol.21, pp.23-38, 2015.

D. Baronio, Altered aquaporins in the brains of mice submitted to intermittent hypoxia model of sleep apnea, Respir. Physiol. Neurobiol, vol.185, pp.217-221, 2013.

A. K. Heye, R. D. Culling, M. D. Valdés-hernández, M. J. Thrippleton, and J. M. Wardlaw, Assessment of blood-brain barrier disruption using dynamic contrast-enhanced MRI: a systematic review, NeuroImage Clin, vol.6, pp.262-274, 2014.

I. L. , A pro-inflammatory role for nuclear factor kappa B in childhood obstructive sleep apnea syndrome

E. Quintana-gallego, Gender differences in obstructive sleep apnea syndrome: a clinical study of 1166 patients, Respir. Med, vol.98, pp.984-989, 2004.

F. Kapsimalis and M. H. Kryger, Gender and obstructive sleep apnea syndrome, part 1: clinical features, Sleep, vol.25, pp.409-416, 2002.

P. M. Macey, Obstructive sleep apnea and cortical thickness in females and males, PLoS ONE, vol.13, p.193854, 2018.

E. Sforza, Cognitive function and sleep related breathing disorders in a healthy elderly population: the synapse study, Sleep, vol.13, issue.3, p.193854, 2010.

C. Puech, X. Delavenne, and N. Perek, The expected characteristics of an in vitro human blood brain barrier model derived from cell lines, for studying how ABC transporters influence drug permeability, J. Drug Deliv. Sci. Technol, vol.45, pp.159-167, 2018.